ResMed | RMD - Sales Revenues


ResMed reported $1.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Artivion USD 95.78M 2.24M Sep/2024
AtriCure USD 140.5M 6.2M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Cochlear AUD 585.65M 586.15M Jun/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
CSL USD 3.54B 4.68B Jun/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 9B 39M Jan/2026
Philips EUR 5.1B 797M Dec/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025
Steris USD 1.5B 470M Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025